Page last updated: 2024-11-05

triamterene and Carcinoma, Ehrlich Tumor

triamterene has been researched along with Carcinoma, Ehrlich Tumor in 1 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolosov, EV1
Smirnova, NV1
Kaz'min, SD1

Other Studies

1 other study available for triamterene and Carcinoma, Ehrlich Tumor

ArticleYear
[The effect of inhibitors of ionic passive transport on the structure of a cell population of Ehrlich's ascites carcinoma].
    Tsitologiia, 1990, Volume: 32, Issue:3

    Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Drug Combinations; Extracellular Space; Hom

1990